Lam Research Corporation (NASDAQ:LRCX) Receives $152.87 Average PT from Brokerages
by Amy Steele · The Cerbat GemLam Research Corporation (NASDAQ:LRCX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the thirty-six research firms that are covering the company, Marketbeat.com reports. Ten analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $152.8733.
A number of analysts have commented on the stock. B. Riley boosted their price target on shares of Lam Research from $160.00 to $175.00 and gave the stock a “buy” rating in a research report on Monday, October 20th. Wells Fargo & Company boosted their target price on Lam Research from $135.00 to $145.00 and gave the stock an “equal weight” rating in a report on Thursday, October 23rd. Barclays set a $142.00 price target on Lam Research and gave the company an “equal weight” rating in a research note on Monday, October 20th. Evercore ISI boosted their price objective on Lam Research from $115.00 to $170.00 and gave the stock an “outperform” rating in a research note on Thursday, October 23rd. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $170.00 price objective on shares of Lam Research in a report on Thursday, October 23rd.
View Our Latest Research Report on Lam Research
Insider Buying and Selling at Lam Research
In related news, SVP Vahid Vahedi sold 52,190 shares of the business’s stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the sale, the senior vice president directly owned 251,047 shares in the company, valued at $34,870,428.30. The trade was a 17.21% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Bethany Mayer sold 1,298 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the sale, the director owned 1,652 shares of the company’s stock, valued at $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 102,608 shares of company stock valued at $14,916,496 over the last quarter. Company insiders own 0.31% of the company’s stock.
Institutional Investors Weigh In On Lam Research
Institutional investors and hedge funds have recently modified their holdings of the stock. Brighton Jones LLC raised its holdings in Lam Research by 1,032.4% during the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock worth $1,025,000 after buying an additional 12,936 shares during the period. New Age Alpha Advisors LLC acquired a new stake in shares of Lam Research during the first quarter valued at approximately $963,000. Chicago Partners Investment Group LLC lifted its position in shares of Lam Research by 31.2% in the 1st quarter. Chicago Partners Investment Group LLC now owns 14,532 shares of the semiconductor company’s stock valued at $1,091,000 after acquiring an additional 3,456 shares in the last quarter. AlphaCore Capital LLC lifted its position in shares of Lam Research by 118.8% in the 1st quarter. AlphaCore Capital LLC now owns 6,279 shares of the semiconductor company’s stock valued at $458,000 after acquiring an additional 3,409 shares in the last quarter. Finally, Townsquare Capital LLC boosted its stake in Lam Research by 13.2% in the 1st quarter. Townsquare Capital LLC now owns 90,326 shares of the semiconductor company’s stock worth $6,567,000 after purchasing an additional 10,539 shares during the period. 84.61% of the stock is owned by institutional investors and hedge funds.
Lam Research Stock Up 1.9%
Shares of Lam Research stock opened at $165.81 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. Lam Research has a 1-year low of $56.32 and a 1-year high of $167.15. The business’s fifty day moving average price is $151.29 and its two-hundred day moving average price is $118.75. The company has a market capitalization of $208.26 billion, a P/E ratio of 36.52, a PEG ratio of 1.67 and a beta of 1.77.
Lam Research (NASDAQ:LRCX – Get Free Report) last released its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter in the prior year, the business posted $0.86 earnings per share. The company’s revenue for the quarter was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, research analysts forecast that Lam Research will post 3.71 EPS for the current year.
Lam Research Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.6%. Lam Research’s dividend payout ratio (DPR) is 22.91%.
Lam Research Company Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Stories
- Five stocks we like better than Lam Research
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers
- How to Read Stock Charts for Beginners
- 10X Gains? These 3 Robotics Stocks Could Explode by 2035
- Basic Materials Stocks Investing
- Anheuser-Busch Buys BeatBox to Win Over Younger Drinkers